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Intestinal ion transportZn2+ is effective in the treatment of acute diarrhea, but its mechanisms are not completely understood. We
previously demonstrated that Zn2+ inhibits the secretory effect of cyclic adenosine monophosphate but not
of cyclic guanosine monophosphate in human enterocytes. The aim of the present study was to investigate
whether Zn2+ inhibits intestinal ion secretion mediated by the Ca2+ or nitric oxide pathways. To investigate
ion transport we evaluated the effect of Zn2+ (35μM) on electrical parameters of human intestinal epithelial
cell monolayers (Caco2 cells) mounted in Ussing chambers and exposed to ligands that selectively increased
intracellular Ca2+ (carbachol 10−6M) or nitric oxide (interferon-γ 300UI/ml) concentrations. We also
measured intracellular Ca2+ and nitric oxide concentrations. Zn2+ signiﬁcantly reduced ion secretion elicited
by carbachol (−87%) or by interferon-γ (−100%), and inhibited the increase of intracellular Ca2+ and nitric
oxide concentrations. These data indicate that Zn2+ inhibits ion secretion elicited by Ca2+ and nitric oxide by
directly interacting with the enterocyte. They also suggest that Zn2+ interferes with three of the four main
intracellular pathways of intestinal ion secretion that are involved in acute diarrhea.iversity of Naples “Federico II”,
7462680.
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Acute diarrhea is a major health problem especially for children in
developing countries (Black et al., 2003). Microbial infection is themain
cause of acute diarrheal diseases (Cheng et al., 2005). Oral rehydration
solution (ORS) prevents dehydration but does not reduce the severity
and duration of diarrhea (Guarino et al., 2001). The ideal treatment for
acute diarrhea is replacement of water and electrolytes combined with
medication that inhibits intestinal hypersecretion without affecting
motility. Several randomized controlled trials and meta-analyses
showed that Zn2+ reduces the severity and duration of diarrhea (Bahl
et al., 2002; Bhatnagar et al., 2004; Bhutta et al., 2000;Hoque andBinder,
2006; INCLEN childnet Zinc Effectiveness for Diarrhea (IC-ZED) Group,
2006; Lazzerini andRonfani, 2008; Roy et al., 2008).Moreover, theWHO
and UNICEF recommend Zn2+ for the universal treatment of childhood
acute diarrhea (WHO/UNICEF, 2004). However, the mechanisms of
action of Zn2+ in the treatment of acute diarrhea are not completely
known. Consequently, a major question is whether the information
available about its mechanism of action is sufﬁcient to support the
universal use of Zn2+ in the treatment of acute diarrhea together withORS (Bhatnagar et al., 2004; Lazzerini and Ronfani, 2008; Berni Canani
and Ruotolo, 2006). It is generally agreed that enteric pathogens
determine ﬂuid secretion through 4 major intracellular signal trans-
duction pathways: 1) cAMP; 2) cGMP; 3) intracellular Ca2+ ([Ca2+]i);
and 4) nitric oxide (NO) (Fasano, 2002). Using an in vitro model, we
previously demonstrated that ZnCl2 stimulates ion absorption in human
enterocytes (Berni Canani et al., 2005). To determine whether the pro-
absorptive effects of ZnCl2 were speciﬁcally related to zinc ion, we
carried out parallel experiments with ZnCl2, Zn(C2H3O2)2, ZnSO4 and
MgCl2. All these zinc salts induced a decrease in Isc identical to that
observed with ZnCl2. In contrast, the addition of MgCl2 at an equimolar
concentration did not affect the electrical parameters, which indicates
that the pro-absorptive effect was selectively related to zinc (Berni
Canani et al., 2005). In addition, ZnCl2 prevented Cholera toxin-induced
active ion secretion bymodulating intracellular cAMP concentration. On
the contrary, ZnCl2 did not affect E. coli heat-stable enterotoxin-cGMP-
mediated ion secretion (Berni Canani et al., 2005). These ﬁndings
suggest that Zn2+ exerts a selective effect against intestinal pathogens
and raises the question: could Zn2+ interfere with other diarrheal
mechanisms elicited by diverse pathogens?
Toxins produced by Ciguatera ﬁsh, Clostridium difﬁcile, Cryptos-
poridium parvum, Rotavirus (the non structural protein 4, NSP4), He-
licobacter pylori, and Vibrio parahaemolyticus can exert a direct
secretory effect on the intestine by modifying [Ca2+]i (Berni Cananid nitric oxide-mediated ion secretion in human
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1995). We previously reported that the transactivator factor peptide
(Tat) produced by HIV-1 induces ion secretion by a Ca2+-mediated
mechanism (Berni Canani et al., 2003a,b). Subsequently, we reported
that pre-incubation of human enterocytes with Zn2+ resulted in an
almost total inhibition of the Tat-induced ion secretion that triggers a
speciﬁc mechanism of HIV-1-related diarrhea (Berni Canani et al.,
2007). This ﬁnding could explain the reduction of diarrhea observed
in patients with HIV-infection during Zn2+ supplementation (Bobat
et al., 2005) and suggests that Zn2+ could play a role also in Ca2+-
mediated diarrhea. Finally, it has been demonstrated that Zn2+ can
modulate [Ca2+]i homeostasis in colonocyte cell culture in basal
condition (Hershﬁnkel et al., 2001).
The importance of NO as a second messenger in intestinal ion
secretion is well recognized. The pathogenic effects exerted by NO
are concentration-dependent (Wingertzahn et al., 2003) and
associated with increased NO production triggered by inducible
NO synthase isoforms (iNOS) that are involved in some infectious
and non-infectious diarrheal diseases (Fasano, 2002; Xu et al., 2002).
The fact that zinc is an NO scavenger (Hershﬁnkel et al., 2001)
supports the possibility that Zn2+ could be effective in NO-induced
ion secretion.
In this study, we investigated the effect of Zn2+ on intestinal ion
secretionmediated by the Ca2+ andNO intracellular signal transduction
pathways. To this aim, we used a human enterocyte cell line model
(Caco2) that has been validated in a study of intestinal transepithelial
ion transport (Moltedo et al., 2000).
2. Materials and methods
2.1. Reagents and cell culture
Chemicals were obtained from Sigma Chemical Co (St. Louis, MO,
USA). Culture medium was obtained from Life Technologies GIBCO
BRL (Mascia e Brunelli, Milan, Italy). Transwell ﬁlters and supports
were obtained from Costar (Costar Italia, Milan, Italy). Caco2 cells
were obtained from the American Type Culture Collection (Rockville,
MD, USA). Cells were grown in Dulbecco's Modiﬁed Eagle's Medium
(DMEM) that had a high glucose concentration (4.5 g/l) and that was
supplemented with 10% fecal calf serum, 1% nonessential amino acids,
penicillin (50 mU/ml), streptomycin (50 mg/ml) and were incubated
in 5% CO2–95% air. The medium was changed daily.
2.2. Ion transport studies
Caco2 cells were grown on uncoated polycarbonate transwell ﬁlters
and were used in intestinal ion transport studies at 15 days post-
conﬂuence as previously described (Berni Canani et al., 1999). The ﬁlter
area was 4.9 cm2. Each ﬁlter was mounted in a Ussing chamber (WPI,
Sarasota, FL, USA) as a ﬂat sheet between the mucosal and the serosal
compartments. Each compartment contained 5 ml of Ringer's solution
(pH 7.4) with the following composition inmmol/l: NaCl (114), KCl (5),
Na2HPO4 (1.65), NaH2PO4 (0.3), CaCl2 (1.25),MgCl2 (1.1), NaHCO3 (25),
glucose (10); the buffer was constantly gassed with 95% O2–5% CO2 and
was connected to a thermostat-regulated circulating pump to maintain
a temperature of 37 °C. The following electrical parameters were
measured or calculated as described elsewhere (Berni Canani et al.,
2005, Field et al., 1971), before and after themucosal or serosal addition
of the testing substance: transepithelial potential difference (PD), short-
circuit current (Isc) and tissue ionic conductance (G). Isc was expressed
asmicroamperes per square centimeter (μA/cm2), G asmillisiemens per
square centimeter (mS/cm2), and PD as millivolts (mV) (Field et al.,
1971). Cell viability was evaluated bymeasuring the electrical response
to the serosal addition of theophylline (5 mM) at the end of each
experiment. In Ussing chambers, Caco2 cell monolayers were exposed
to awell established agent of the Ca2+-mediated ion secretion pathway,Please cite this article as: Berni Canani, R., et al., Zinc inhibits calci
enterocytes, Eur. J. Pharmacol. (2009), doi:10.1016/j.ejphar.2009.09.042i.e., carbachol (10−6M), to the serosal side, aloneor in combinationwith
ZnCl2 (35μM). The two agents were used at themaximal effective dose,
as previously established in the same experimental model (Moltedo
et al., 2000). To investigate the effect of Zn2+ on NO-mediated ion
secretion, we added IFN-γ (300UI/ml) to the serosal side of Caco2 cells.
Interferon-γ is an agonist of iNOS and stimulates Cl− secretion through
the increase of NO (Chavez et al., 1999). To allow activation of iNOS-
mediated NO production, the cells were mounted in Ussing chambers
after 1 h of incubation with IFN-γ, and the electrical parameters were
measured in the presence or absence of ZnCl2 (35μM). To obtain
additional evidence of the effect of ZnCl2 on NO-mediated ion secretion,
we repeated these experiments using the NO donor sodium nitroprus-
side (10 mM) added to the serosal side.
2.3. [Ca2+]i measurement
The [Ca2+]i was measured by single cell computer-assisted
videoimaging (Secondo et al., 2000). Brieﬂy, Caco2 cells, grown on
glass coverslips, were loaded with 6 µM Fura-2 acetoxymethyl ester
(Fura-2 AM) for 1 h at room temperature in Krebs solution containing
the following substances (in mM): 5.5 KCl, 160 NaCl, 1.2 MgCl2, 1.5
CaCl2, 10 glucose, and 10 Hepes-NaOH, pH 7.4. At the end of Fura-2 AM
loading, the coverslips were placed in a perfusion chamber (Medical
System, Co. Greenvale, NY, USA) mounted into the stage of a Zeiss
Axiovert 200microscope (Carl Zeiss, Germany) equipped with a FLUAR
40× oil objective lens. The experiments were carried out with a digital
imaging system consisting of a MicroMax 512BFT cooled CCD camera
(Princeton Instruments, Trenton, NJ, USA), a LAMBDA 10-2 ﬁlter
wheeler (Sutter Instruments, Novato, CA, USA) and Meta-Morph/
MetaFluor Imaging System software (Universal Imaging, West Chester,
PA, USA). After loading, cells were illuminated with light alternating
between wavelengths of 340 and 380 nm using a xenon arc lamp. The
emitted light was passed through a 512 nm barrier ﬁlter. Fura-2 AM
ﬂuorescence intensitywasmeasured every 3 s. Ratiometric valueswere
automatically converted by a speciﬁc software into [Ca2+]i using a pre-
loaded calibration curve obtained in preliminary experiments (Gryn-
kiewicz et al., 1985; Secondo et al., 2000).
2.4. Nitrite/nitrate concentration measurement
The combined concentration of nitrite/nitrate (NO2−/NO3−), the
end stable products of NO in the culture medium, was determined by
the Griess reaction as previously described (Carlson et al., 2006).
Therefore, total NO2−/NO3− production is referred to as “NO produc-
tion” in the text. Caco2 cell monolayers were grown on plates and
used at 15 days post-conﬂuence. Cells were stimulated with IFN-γ
(300UI/ml) for 60 min in the absence or in the presence of ZnCl2
(35μM). Cells exposed to vehicle alone served as control.
2.5. Statistics
Each experiment was repeated 3 times. Continuous variables
were expressed as mean±standard deviation (SD). We used the t-
test for equality of means to compare variables among the different
groups. All tests of signiﬁcance were two-sided. A P value of 0.05 was
considered signiﬁcant. Statistical analysis was performed using the
SPSS software package for Windows (release 16.0.0; SPSS Inc.,
Chicago, IL, USA) and Stats direct (release 2.6.6).
3. Results
3.1. Zn2+ effects on Ca2+-mediated intestinal ion secretion
To investigate the effects of Zn2+ on Ca2+-mediated intestinal ion
secretion, we treated Caco2 cell monolayers to the maximal effective
dose of carbachol (10−6M) added to the serosal side in the absence orum-mediated and nitric oxide-mediated ion secretion in human
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carbachol to the serosal side of Caco2 cell monolayers induced a
prompt increase in Isc. This effect was entirely due to an increase of PD
because G was unchanged. Pre-incubation with ZnCl2 for 20 min
resulted in a signiﬁcant inhibition of carbachol-induced ion secretion
(Fig. 1). To evaluate whether Zn2+ can modulate [Ca2+]i homeostasis
in human enterocytes, Caco2 cells, pre-loaded with Fura-2 AM, were
superfused with carbachol (10−6M) in normal Krebs solution
containing physiological concentrations of Ca2+ (i.e., 1.2 mM). In
response to this stimulus, approximately 50% of cells displayed a
transient peak of [Ca2+]i, whereas the other 50% showed a slow
increase of [Ca2+]i that reached a plateau after about 8 min (Fig. 2,
panels A and B, respectively). Despite the difference in the pattern of
response, the maximum increase of [Ca2+]i was similar in both
subpopulations of cells (Fig. 2, panels D and E). Pre-incubation with
35μM ZnCl2 for 20 min signiﬁcantly inhibited the carbachol-induced
increase of [Ca2+]i (Fig. 2: panels C and F).
3.2. Effects of Zn2+on NO-mediated intestinal ion secretion
To investigate the effects of Zn2+ on NO-mediated intestinal ion
secretion, we treated Caco2 cell monolayers with the maximal
effective dose of IFN-γ (300UI/ml) added to the serosal side in the
absence or presence of 35 μMZnCl2. As shown in Fig. 3, the addition of
IFN-γ to the serosal side of Caco2 cell monolayers induced an increase
in Isc. This effect was entirely due to an increase of PD because G
remained unchanged. As shown in Fig. 3, exposure to ZnCl2 for 20 min
completely inhibited IFN-γ-induced ion secretion. We next evaluated
the effect of Zn2+ on NO production. Basal NO2−/NO3− concentrations
were reduced consequent to the addition of ZnCl2 (Fig. 4). Pre-
treatment with ZnCl2 (35μM) inhibited the increase in NO concen-
tration induced by IFN-γ (300UI/ml) (Fig. 4). The addition of sodium
nitroprusside to Caco2 cell monolayers induced an increase in Isc. The
maximal effect was observed 20 min after the addition of sodium
nitroprusside (ΔIsc 2.42±0.4 µA/cm2). The effect was entirely due to
an increase of PD because G remained unchanged. Pre-incubationFig. 1. Effects of Zn2+ on carbachol-induced intestinal ion secretion. Time course effects of
carbachol (10−6M) and ZnCl2 (35 µM), alone or in combination, on short-circuit current
(Isc) in Caco2 cells mounted in Ussing chambers. The arrows indicate the time of addition
of each agent. Carbachol induced a signiﬁcant increase in Isc, consistent with Cl− secretion
(*P<0.01 vs. control). ZnCl2 induced a signiﬁcant decrease in Isc, consistent with chloride
absorption (*P<0.01 vs. control). Preload with ZnCl2 resulted in substantial inhibition of
carbachol-induced ion secretion (*P<0.01 carbachol plus Zn2+ vs. carbachol alone),
which is consistent with inhibition of Ca2+-mediated ion secretion. The upper right side of
the ﬁgure shows the maximal Isc modiﬁcations observed after the addition of carbachol
(10−6M) and ZnCl2 (35 µM), alone or in combination. Preload with ZnCl2 resulted in
signiﬁcant inhibition of maximal Isc modiﬁcation induced by carbachol. Each experiment
was repeated at least 3 times. Results are expressed as means±S.D.
Please cite this article as: Berni Canani, R., et al., Zinc inhibits calci
enterocytes, Eur. J. Pharmacol. (2009), doi:10.1016/j.ejphar.2009.09.042with ZnCl2 (35μM) for 20 min resulted in a signiﬁcant inhibition of ion
secretion elicited by this NO donor (10 mM) (−69.5%, P<0.01).4. Discussion
Here we report evidence that, by directly interacting with
enterocytes, Zn2+ reduces intestinal Cl− secretion elicited by the
Ca2+- and NO-mediated intracellular pathways. Zinc signiﬁcantly
inhibited carbachol-induced ion secretion, and the effect on
intestinal ion transport was paralleled by [Ca2+]i modiﬁcations. In
fact, pre-incubation with Zn2+ signiﬁcantly inhibited the increase of
[Ca2+]i induced by carbachol in Caco2 cells. Carbachol, by activating
M-type receptors, induces hydrolysis of polyphosphoinositides and
mobilization of [Ca2+]i stores as a consequence of activation of the G
protein-phospholipase-C pathway. This in turn elicits activation of
capacitative Ca2+ entry through the store-operated-Ca2+-channels
(Carlson et al., 2006). Our data suggest that in enterocytes, both these
mechanisms contribute to [Ca2+]i modiﬁcations in response to
carbachol. The former produces a rapid but transient response and
the latter induces a long-lasting event. HIV-1 Tat protein induced
similar effects in Caco2 cells (Berni Canani et al., 2003). As observed
in other extraintestinal cell types (Kresse et al., 2005; Priel and
Hershﬁnkel, 2006), we found that Zn2+ inhibits both mechanisms in
Caco2 cells.
Our results are consistentwith the ﬁnding that Zn2+ reduces Ca2+-
dependent ion secretion in piglet small intestinal epithelium (Carlson
et al., 2006), but contrast with the ﬁnding that Zn2+ does not inhibit
Ca2+-mediated secretion in isolated rat ileum (Hoque et al., 2005). In
addition to factors related to the type of experimental model, these
discrepancies may be related to the different Zn2+ doses used in these
studies. In fact, we previously reported that in basal condition the
effects of Zn2+ on intestinal ion transport are strictly dose-related.
Within a normal plasma concentration (i.e., <40μM), Zn2+ induces
ion absorption. In contrast, at higher concentrations (i.e., >100μM),
Zn2+ induces ion secretion as demonstrated by an increase in Isc
observed in human enterocytes (Berni Canani et al., 2005).
Nitric oxide is the most recently discovered pathway involved in
intestinal ion (Fasano, 2002). We show that Zn2+ signiﬁcantly
inhibited intestinal Cl− secretion induced by IFN-γ or by the NO
donor sodium nitroprusside and that the addition of Zn2+ to Caco2
cells was associated with a decrease in NO production. These results
conﬁrm previous observations, obtained in in vivo animal models,
showing that Zn2+ inhibits lipopolysaccharides and IL-1-induced
diarrhea by inducing a reduction of NO production, and by removing
NO chemically generated in the gut (Wingertzahn et al., 2003). There
is compelling evidence that Zn2+ and NO play regulatory roles in
intestinal ion transport. A low NO concentration sustained by
constitutive NO synthase maintains the physiological intestinal ion
pro-absorptive tone (Berni Canani et al., 2003a,b). On the contrary, an
excess of NO production stimulated by pro-inﬂammatory cytokines or
microbial toxins induces intestinal ﬂuid secretion through up-
regulation of iNOS (Wingertzahn et al., 2003). This mechanism may
be activated in intestinal infections and inﬂammation (Chavez et al.,
1999) and over-expression of the iNOS gene has been demonstrated
in a Zn2+-deﬁcient animal model (Cui et al., 1997). The results of our
study suggest that Zn2+ is part of this network in the enterocyte.
The antisecretory effects of Zn are particularly relevant to
childhood diarrhea. In fact, infectious diarrhea is one of the leading
causes of pediatric morbidity and mortality worldwide (Lazzerini and
Ronfani, 2008) and Rotavirus, the major agent of acute diarrhea,
stimulates Cl− secretion through a phospholipase C-dependent Ca2+
signaling pathway induced by NSP4 (Lorrot and Vasseur, 2007). Our
experimental data showing that Zn2+ exerts a direct effect on Ca2+-
induced intestinal ion secretion support the use of Zn2+ in the
treatment of childhood diarrhea due to Rotavirus.um-mediated and nitric oxide-mediated ion secretion in human
Fig. 3. Effects of Zn
2+
on interferon-γ-induced ion secretion. Time course effects of IFN-γ
(300UI/ml) and ZnCl2 (35 µM), alone or in combination, on short-circuit current (Isc) in
Caco2 cells mounted in Ussing chambers. The arrows indicate the time of addition of each
agent. IFN-γ induced a signiﬁcant increase in Isc, consistent with Cl−secretion (* P<0.01
vs. control). ZnCl2 induced a signiﬁcantdecrease in Isc, consistentwith chlorideabsorption.
Preload with ZnCl2 resulted in substantial inhibition of IFN-γ-induced ion secretion
(*P<0.01 IFN-γ plus Zn
2+
vs. IFN-γ alone), consistent with inhibition of NO-mediated ion
secretion. The upper right side of theﬁgure shows themaximal Iscmodiﬁcations observed
after the addition of IFN-γ (300UI/ml) and ZnCl2 (35 µM) alone or in combination. Preload
with ZnCl2 resulted in signiﬁcant inhibition of maximal Isc modiﬁcation induced by IFN-γ.
Each experiment was repeated at least 3 times. Results are expressed as means±S.D.
Fig. 2. Effect of Zn
2+
on [Ca
2+
]
i
increase induced by carbachol. Panels A and B report the effect of carbachol (10
−6
M) on [Ca
2+
]i in two single Caco2 cells loadedwith Fura-2 A (see Section
2). These traces are representative of 150 cells recorded in 3 different experiments. The arrows showwhen the drugwas put in the perfusion chamber. Panel C is a representative trace of
the effect exerted by Zn
2+
(35 µM) on [Ca
2+
]
i
increase induced by carbachol (10
−6
M). This trace is representative of 100 cells recorded in 3 different experiments. The arrows show
when the drugwas put in the perfusion chamber. Panels D, E and F show themaximal [Ca
2+
]i modiﬁcations observed. The experiments were performedwith 1.2 mM extracellular Ca
2+
.
Results are expressed as means±S.D. * P<0.01 peak vs. basal value.
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enterocytes, Eur. J. Pharmacol. (2009), doi:10.1016/j.ejphar.2009.09.042The number of intestinal pathogens that induce diarrhea via NO is
limited, but not negligible, Shigella enterotoxin 1 exerts an irreversible,
dose-dependent enterotoxic effect via an increased NO intestinal
concentration that is partially blocked by iNOS inhibitors (Fasano,
2002). However, high NO production can also contribute to diarrhea by
acting as a secretagogue, particularly in inﬂammatory diarrhea. In thisFig. 4. Effects of Zn2+ on the end stable degradation products of NO (NO2−/NO3−). Total
NO2−/NO3− production in Caco2 cells determined in basal condition, in the presence of
ZnCl2 (35 μM) and IFN-γ (300UI/ml), alone and in combination. Data are means±S.D.
of 3 different observations. *P<0.01 IFN-γ plus Zn2+vs. IFN-γ alone.
um-mediated and nitric oxide-mediated ion secretion in human
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in the treatment of diarrhea induced by intestinal inﬂammatory
diseases. In addition to its effects on ion transport, Zn2+ stimulates
enterocyte growth and differentiation, reduces intestinal permeability
and positively regulates oxidative stress and inﬂammation (Hoque and
Binder, 2006). Few other drugs exert such a variety of beneﬁcial effects
in the intestine. As an adjunct to ORS, Zn2+ has the potential to improve
themanagementofdiarrhea at affordable costs andwithout theneed for
major equipment or medical facilities. Recently, it has been reported
that Zn2+enhanced clinical recovery and reduced stool output in severe
diarrhea caused by Vibrio cholerae in children (Roy et al., 2008). It has
been estimated that implementation of the WHO/UNICEF recommen-
dations on theuseof Zn2+ in the treatmentof diarrhea could save nearly
400,000 lives annually (WHO/UNICEF, 2004), and that Zn2+ supple-
mentation together with ORS is less expensive and more effective than
ORS alone in the treatment of acute diarrhea (Lazzerini and Ronfani,
2008). The composition of ORS has undergonemany changes in the last
30 years (Guarino et al., 2001), our results support the use of a new
super-ORS containing Zn2+, but further clinical studies are needed to
explore the selective effects of Zn2+ against speciﬁc pathogens
responsible for diarrhea.
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